估算sdLDL-C/LDL-C不一致性关联晚期心血管-肾脏-代谢综合征及不良预后
使用Sampson公式估算sdLDL-C,以估算sdLDL-C/LDL-C百分位差绝对值≥10定义不一致性。结果显示估算sdLDL-C及其与LDL-C的不一致性与晚期CKM、心血管事件和死亡率相关。
要点
- 估算sdLDL-C与LDL-C不一致性高者晚期CKM患病率更高
- 估算sdLDL-C升高与CHARLS队列心血管事件风险增加相关
- 不一致性每增加1个SD与全因死亡率和心血管死亡率升高相关
核心结论
- 估算sdLDL-C及其与LDL-C的不一致性与晚期CKM、心血管事件和死亡率相关
- 估算sdLDL-C/LDL-C不一致性可能反映与不良CKM结局相关的LDL脂质异质性
研究设计与样本
- 采用观察性队列设计,NHANES进行调查加权分析,CHARLS使用社区层面聚类稳健标准误
- 通过Sampson公式估算sdLDL-C,以估算sdLDL-C/LDL-C百分位差绝对值≥10定义不一致性
主要发现
- 在给定的估算lbLDL-C水平下,估算sdLDL-C较高及估算sdLDL-C/LDL-C不一致性较大均与两个队列晚期CKM患病率增加相关
- NHANES中不一致性高组与低组相比晚期CKM的OR为2.89,95%CI为2.39-3.50
- CHARLS中给定的估算lbLDL-C水平下估算sdLDL-C与心血管事件风险呈正相关,但不一致性关联在校正基线CKM分期后减弱
- NHANES中不一致性每增加1个SD与全因死亡率升高15%相关,与心血管死亡率升高20%相关
- CHARLS中不一致性每增加1个SD与全因死亡率升高23%相关
关键数值与推荐
- 不一致性定义为估算sdLDL-C/LDL-C百分位差绝对值≥10个百分位
- NHANES中不一致性高组与低组相比晚期CKM的OR为2.89,95%CI为2.39-3.50
- NHANES中不一致性每增加1个SD与全因死亡率升高15%相关
- NHANES中不一致性每增加1个SD与心血管死亡率升高20%相关
- CHARLS中不一致性每增加1个SD与全因死亡率升高23%相关
临床怎么用
- 估算sdLDL-C/LDL-C不一致性可作为反映LDL脂质异质性的指标用于评估CKM相关风险
- 在LDL-C水平相似的个体中关注sdLDL-C有助于识别心血管和死亡风险较高的人群
局限性
- sdLDL-C为通过Sampson公式估算而非直接测定
- 不一致性关联在CHARLS队列中校正基线CKM分期后减弱
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ABSTRACT Background sdLDL-C is a more atherogenic subfraction of LDL particles. We aimed to investigate the associations of sdLDL-C and its discordance with LDL-C with advanced stages, incident cardiovascular disease (CVD) and mortality among adults across the cardiovascular–kidney–metabolic (CKM) syndrome spectrum. Methods This study included adults from two cohorts: 16 992 participants from the National Health and Nutrition Examination Survey (NHANES, 1999–2018) and 8252 from the China Health and Retirement Longitudinal Study (CHARLS, 2011–2020) across CKM Stages 0–4. sdLDL-C was estimated (E-sdLDL-C) via Sampson's equation. Discordance was defined as an absolute E-sdLDL-C/LDL-C percentile difference of ≥ 10 percentiles. Logistic regression assessed advanced CKM, and Cox models evaluated associations with incident CVD in CHARLS and mortality in both cohorts. Survey-weighted analyses were applied in NHANES, and CHARLS models were fitted with community-level cluster-robust standard errors. Results Higher E-sdLDL-C at a given level of E-lbLDL-C and greater E-sdLDL-C/LDL-C discordance were each associated with increased advanced CKM prevalence across both cohorts (discordantly high vs. low in NHANES: OR: 2.89, 95% CI: 2.39–3.50). E-sdLDL-C at a given level of E-lbLDL-C was positively associated with incident CVD risk in CHARLS, whereas the discordance associations were attenuated after adjustment for baseline CKM stage. Each SD increment in discordance was associated with 15% higher all-cause and 20% higher cardiovascular mortality in NHANES, and 23% higher all-cause mortality in CHARLS. Conclusions E-sdLDL-C and its discordance with LDL-C are associated with advanced CKM, incident CVD and mortality, suggesting that E-sdLDL-C/LDL-C discordance may reflect LDL-related lipid heterogeneity associated with adverse CKM outcomes.
引用
- Diabetes, Obesity and Metabolism:Estimated sdLDL‐C/LDL‐C Discordance Is Associated With Advanced Cardiovascular–Kidney–Metabolic Syndrome, Incident Cardiovascular Disease and Mortality: Evidence From Two Population‐Based Cohorts
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。